StockNews.AI
NUTX
StockNews.AI
3 days

Kirby McInerney LLP Announces Investigation Against Nutex Health Inc. on Behalf of Investors

1. Kirby McInerney LLP is investigating Nutex for potential securities law violations. 2. Blue Orca Capital raised concerns over Nutex's 20-fold share price surge. 3. Allegations suggest inflated billing practices linked to HaloMD affecting revenue legitimacy. 4. Nutex shares dropped by approximately 10% and then 16% on negative news. 5. Nutex delayed quarterly filings, compounding investor uncertainty.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The combination of securities investigations and declining share prices signifies serious underlying issues, similar to past collapses in companies involved in financial fraud.

How important is it?

Significant investor concerns are raised by legal investigations, which typically lead to stock price volatility.

Why Short Term?

Immediate reactions to the investigation and filing delays are impacting sentiments and share prices quickly.

Related Companies

HALONUTX
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). The investigation concerns whether Nutex and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] On July 22, 2025, Blue Orca Capital published a research report raising concerns about Nutex Health’s recent 20-fold share price surge. The report alleges that the company’s growth was artificially driven by a third-party arbitration vendor, HaloMD, which facilitated inflated out-of-network billing awards. According to Blue Orca, multiple federal lawsuits now allege that HaloMD orchestrated a fraudulent and racketeering scheme that siphoned millions from insurers, casting doubt on the legitimacy of Nutex’s reported revenue increases. On this news, the price of Nutex shares declined by $11.18 per share, or approximately 10.05%, from $111.19 per share on July 21, 2025 to close at $100.01 on July 22, 2025. Then on August 14, 2025, Nutex announced it would delay filing its quarterly financial statements for the period ending June 30, 2025, citing incomplete accounting adjustments. On this news, the price of Nutex shares declined by $18.22 per share, or approximately 16.39%, from $111.13 per share on August 14, 2025 to close at $92.91 on August 15, 2025 If you purchased or otherwise acquired Nutex securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out the form below to discuss your rights or interests with respect to these matters without any cost to you. [CONTACT US] Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. ContactsKirby McInerney LLPThomas W. Elrod, Esq.212-699-1180https://www.kmllp.cominvestigations@kmllp.com

Related News